CAS RN: 1620576-64-8
1-(4-(5-(5-amino-6-(5-(tert-butyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1H-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one
Product Availability
Choose a grade to view its available package options.
13 package records9 with current stock3 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260204 |
100mg |
Out of stock |
| | Inquiry |
| Batchno.20260408 |
10mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260613 |
250mg |
Out of stock |
| | Inquiry |
| Batchno.20250112 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251003 |
50mg |
Out of stock |
| | Inquiry |
| Batchno.20250806 |
5mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250608 |
5mg / 25mg / 100mg |
Out of stock |
| 5-7 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250223 |
1ml |
In stock |
| | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260216 |
100mg |
In stock |
| | Inquiry |
| Batchno.20251104 |
10mg |
In stock |
| | Inquiry |
| Batchno.20250211 |
25mg |
In stock |
| | Inquiry |
| Batchno.20260302 |
50mg |
In stock |
| | Inquiry |
| Batchno.20250822 |
5mg |
In stock |
| | Inquiry |
-
Product code:
starshine_CAS1620576-64-8
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1620576-64-8 / 1-[4-[5-[5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-ethyl-1,2,4-triazol-3-yl]piperidin-1-yl]-3-hydroxypropan-1-one
Standard CAS: 1620576-64-8
Multi CAS: No
Basic Information
CAS
1620576-64-8
Multi CAS
No
Molecular Formula
C22H31N9O3
Molecular Weight
469.500000
Exact Mass
469.254986
SMILES
CCN1C(=NC(=N1)C2CCN(CC2)C(=O)CCO)C3=CN=C(C(=N3)C4=NN=C(O4)C(C)(C)C)N
InChI
InChI=1S/C22H31N9O3/c1-5-31-19(26-18(29-31)13-6-9-30(10-7-13)15(33)8-11-32)14-12-24-17(23)16(25-14)20-27-28-21(34-20)22(2,3)4/h12-13,32H,5-11H2,1-4H3,(H2,23,24)
InChIKey
ZGRDYKFVDCFJCZ-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
34
Aromatic heavy atom count
16
Fraction Csp3
0.59
Rotatable bonds
6
H-bond acceptors
11
H-bond donors
2
Molar refractivity
123.38
TPSA
161.97
LogP / Solubility
WLOGP
1.77
MLOGP
1.59
XLogP3
0.1
Consensus LogP
1.15
Log S (ESOL)
-3.82
Class (ESOL)
Poorly soluble
Log S (Ali)
-4.69
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.9
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.33
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3
Safety & Transport
Pictogram(s)
Health Hazard
Signal
Danger
GHS Hazard Statements
H372 (100%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]
Precautionary Statement Codes
P260, P264, P270, P319, and P501